array:19 [
  "pii" => "X0211699500025419"
  "issn" => "02116995"
  "estado" => "S300"
  "fechaPublicacion" => "2000-02-01"
  "documento" => "article"
  "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
  "subdocumento" => "fla"
  "cita" => "Nefrologia. 2000;20 Supl 1:76"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:2 [
    "total" => 1444
    "formatos" => array:3 [
      "EPUB" => 154
      "HTML" => 1019
      "PDF" => 271
    ]
  ]
  "itemSiguiente" => array:15 [
    "pii" => "X0211699500025400"
    "issn" => "02116995"
    "estado" => "S300"
    "fechaPublicacion" => "2000-02-01"
    "documento" => "article"
    "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
    "subdocumento" => "fla"
    "cita" => "Nefrologia. 2000;20 Supl 1:77"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 1417
      "formatos" => array:3 [
        "EPUB" => 160
        "HTML" => 1014
        "PDF" => 243
      ]
    ]
    "en" => array:8 [
      "idiomaDefecto" => true
      "titulo" => "The effects of anemia on cardiovascular status"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "paginas" => array:1 [
        0 => array:1 [
          "paginaInicial" => "77"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "R. N. FOLEY"
          "autores" => array:1 [
            0 => array:1 [
              "nombre" => "R. N. FOLEY"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699500025400?idApp=UINPBA000064"
    "url" => "/02116995/00000020000000S1/v0_201502091333/X0211699500025400/v0_201502091333/en/main.assets"
  ]
  "itemAnterior" => array:15 [
    "pii" => "X0211699500025427"
    "issn" => "02116995"
    "estado" => "S300"
    "fechaPublicacion" => "2000-02-01"
    "documento" => "article"
    "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
    "subdocumento" => "fla"
    "cita" => "Nefrologia. 2000;20 Supl 1:75"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 1634
      "formatos" => array:3 [
        "EPUB" => 163
        "HTML" => 1192
        "PDF" => 279
      ]
    ]
    "en" => array:8 [
      "idiomaDefecto" => true
      "titulo" => "«NEFROPATÍA DIABÉTICA TIPO II: LA EPIDEMIA DEL SIGLO XXI» New approaches to primary and secondary prevention of diabetic nephropathy"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "paginas" => array:1 [
        0 => array:1 [
          "paginaInicial" => "75"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "G. REMUZZI"
          "autores" => array:1 [
            0 => array:1 [
              "nombre" => "G. REMUZZI"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699500025427?idApp=UINPBA000064"
    "url" => "/02116995/00000020000000S1/v0_201502091333/X0211699500025427/v0_201502091333/en/main.assets"
  ]
  "en" => array:8 [
    "idiomaDefecto" => true
    "titulo" => "«HIPERTENSIÓN Y ENFERMEDAD CARDIOVASCULAR EN PACIENTES CON INSUFICIENCIA RENAL CRÓNICA» Effects of hyperparathyroidism in the pathogenesis of hypertension, left ventricular hypertrophy and cardiovascular disease in CRF patients"
    "tieneTextoCompleto" => true
    "paginas" => array:1 [
      0 => array:1 [
        "paginaInicial" => "76"
      ]
    ]
    "autores" => array:1 [
      0 => array:2 [
        "autoresLista" => "T. B. DRÜEKE"
        "autores" => array:1 [
          0 => array:1 [
            "nombre" => "T. B. DRÜEKE"
          ]
        ]
      ]
    ]
    "textoCompleto" => "NEFROLOGÍA. Vol. XX. Suplemento 1. 2000 «HIPERTENSIÓN Y ENFERMEDAD CARDIOVASCULAR EN PACIENTES CON INSUFICIENCIA RENAL CRÓNICA» Effects of hyperparathyroidism in the pathogenesis of hypertension, left ventricular hypertrophy and cardiovascular disease in CRF patients T. B. Drüeke Necker Hospital, Paris. PTH has been shown to influence cardiac and vascular function and growth, as shown experimentally in in vitro and in vivo etudies, and alco-in-human subjects with normal renal function. Because of the increased prevalence of hyperparathyroidism in chronic renal failure (CRF), these alterations have long been felt to contribute to the increased prevalence of cardiovascular disease and hypertension seen in this patient population. PTH (and also PTHrP) have been shown to increase acutely the force and frequency of contraction of isolated, beating rat cardiomyocytos. It has been, suggested that increased inotropy produced by PTH and PTHrP is due to effects on coronary flow and heart rate and not to effects on contractile function. However, changes induced by PTH occur in association with an increase of cell calcium and cyclic AMP. In isolated myocardial mitochondria PTH uncoupled oxidative phosphorylation and inhibited myocardial energy production, leading to reduced ATP content and impaired activity of creatine kinase. Like the chronic inhibitory effects of PTH on myocardial contractility, these responses could be reversed by verapamil. In a uremic rat model elevated cytosolic Ca2+ in cardiomyocytes was associated with attenuated IGF-1 stimulated protein synthesis that could be reversed either by parathyroidectomy or felodipine, suggesting yet another mechanism by which elevated intracellular calcium and 2.º hyperparathyroidism might modulate myocardial growth and structure in uremia. The above noted experimental studies suggest that prolonged exposure to PTH is associated with a greater intramyocardiocyte Ca2+ and with adverse effects on myocardial metabolism, structure, and function. An increase of cytoplasmic Ca2+ by excessive PTH levels has also been found in uremic patients in whom elevated platelet Ca2+ was correlated with plasma PTH and which could be corrected by parathyroidectomy of calcitriol treatment. 76 In rats with CRF the PTH/PTHrP receptor is downregulated. This may serve to desensitize tissues to PTH effects and thus minimize increases in cellular calcium, possibly as part of a negative feedback mechanism. In humans with CRF, as in 1.º hyperparathyroidism, the presence of 2.º hyperparathyroidism has been associated with increased myocardial calcium content and impaired ventricular systolic and diastolic function. Moreover, both 1.º and 2.º hyperparathyroidism are associated with left ventricular hypertrophy (LVH). There are theoretically several mechanisms by which parathyroid excess could favor LVH and cardiac dysfunction. They include direct trophic effects on cardiomyocytes and interstitial fibroblasts and indirect effects such as a blood pressure increase via hypercalcemia, hyperphosphatemia and anemia, as well as pathologic large and small vessels changes secondary to disturbances of lipid and carbohydrate metabolism and to soft-tissue calcifications associated with chronic PTH excess However, parathyroidectomy is not consistently associated with improvement in left ventricular hypertrophy and function, suggesting either PTH-induced changes became irreversible in the case of long-standing, severe hyperparathyroidism, for example by the induction of interstitial fibrosis, or that other factors contributing to myocardial dysfunction were more important than parathyroid overfunction. In conclusion, the hyperparathyroid stale of chronic renal failure contributes to the cardiovascular pathology seen clinically in uremic patients and also to the excess mortality from cardiovascular causes found in this patient group. REVIEW ARTICLE Rostand SG, Drüeke TB: Parathyroid hormone, vitamin D, and cardiovascular disease in chronic renal failure. Kidney Int 56: 383-392, 1999. "
    "pdfFichero" => "P7-E170-S140-A1913.pdf"
    "tienePdf" => true
  ]
  "idiomaDefecto" => "en"
  "url" => "/02116995/00000020000000S1/v0_201502091333/X0211699500025419/v0_201502091333/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "35407"
    "tipo" => "SECCION"
    "es" => array:2 [
      "titulo" => "Suplementos"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "es"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/02116995/00000020000000S1/v0_201502091333/X0211699500025419/v0_201502091333/en/P7-E170-S140-A1913.pdf?idApp=UINPBA000064&text.app=https://revistanefrologia.com/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699500025419?idApp=UINPBA000064"
]
Compartir
Información de la revista

Estadísticas

Siga este enlace para acceder al texto completo del artículo

«HIPERTENSIÓN Y ENFERMEDAD CARDIOVASCULAR EN PACIENTES CON INSUFICIENCIA RENAL CRÓNICA» Effects of hyperparathyroidism in the pathogenesis of hypertension, left ventricular hypertrophy and cardiovascular disease in CRF patients
T. B. DRÜEKE
Leído
4326
Veces
se ha leído el artículo
1651
Total PDF
2675
Total HTML
Compartir estadísticas
 array:19 [
  "pii" => "X0211699500025419"
  "issn" => "02116995"
  "estado" => "S300"
  "fechaPublicacion" => "2000-02-01"
  "documento" => "article"
  "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
  "subdocumento" => "fla"
  "cita" => "Nefrologia. 2000;20 Supl 1:76"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:2 [
    "total" => 1444
    "formatos" => array:3 [
      "EPUB" => 154
      "HTML" => 1019
      "PDF" => 271
    ]
  ]
  "itemSiguiente" => array:15 [
    "pii" => "X0211699500025400"
    "issn" => "02116995"
    "estado" => "S300"
    "fechaPublicacion" => "2000-02-01"
    "documento" => "article"
    "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
    "subdocumento" => "fla"
    "cita" => "Nefrologia. 2000;20 Supl 1:77"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 1417
      "formatos" => array:3 [
        "EPUB" => 160
        "HTML" => 1014
        "PDF" => 243
      ]
    ]
    "en" => array:8 [
      "idiomaDefecto" => true
      "titulo" => "The effects of anemia on cardiovascular status"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "paginas" => array:1 [
        0 => array:1 [
          "paginaInicial" => "77"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "R. N. FOLEY"
          "autores" => array:1 [
            0 => array:1 [
              "nombre" => "R. N. FOLEY"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699500025400?idApp=UINPBA000064"
    "url" => "/02116995/00000020000000S1/v0_201502091333/X0211699500025400/v0_201502091333/en/main.assets"
  ]
  "itemAnterior" => array:15 [
    "pii" => "X0211699500025427"
    "issn" => "02116995"
    "estado" => "S300"
    "fechaPublicacion" => "2000-02-01"
    "documento" => "article"
    "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
    "subdocumento" => "fla"
    "cita" => "Nefrologia. 2000;20 Supl 1:75"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 1634
      "formatos" => array:3 [
        "EPUB" => 163
        "HTML" => 1192
        "PDF" => 279
      ]
    ]
    "en" => array:8 [
      "idiomaDefecto" => true
      "titulo" => "«NEFROPATÍA DIABÉTICA TIPO II: LA EPIDEMIA DEL SIGLO XXI» New approaches to primary and secondary prevention of diabetic nephropathy"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "paginas" => array:1 [
        0 => array:1 [
          "paginaInicial" => "75"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "G. REMUZZI"
          "autores" => array:1 [
            0 => array:1 [
              "nombre" => "G. REMUZZI"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699500025427?idApp=UINPBA000064"
    "url" => "/02116995/00000020000000S1/v0_201502091333/X0211699500025427/v0_201502091333/en/main.assets"
  ]
  "en" => array:8 [
    "idiomaDefecto" => true
    "titulo" => "«HIPERTENSIÓN Y ENFERMEDAD CARDIOVASCULAR EN PACIENTES CON INSUFICIENCIA RENAL CRÓNICA» Effects of hyperparathyroidism in the pathogenesis of hypertension, left ventricular hypertrophy and cardiovascular disease in CRF patients"
    "tieneTextoCompleto" => true
    "paginas" => array:1 [
      0 => array:1 [
        "paginaInicial" => "76"
      ]
    ]
    "autores" => array:1 [
      0 => array:2 [
        "autoresLista" => "T. B. DRÜEKE"
        "autores" => array:1 [
          0 => array:1 [
            "nombre" => "T. B. DRÜEKE"
          ]
        ]
      ]
    ]
    "textoCompleto" => "NEFROLOGÍA. Vol. XX. Suplemento 1. 2000 «HIPERTENSIÓN Y ENFERMEDAD CARDIOVASCULAR EN PACIENTES CON INSUFICIENCIA RENAL CRÓNICA» Effects of hyperparathyroidism in the pathogenesis of hypertension, left ventricular hypertrophy and cardiovascular disease in CRF patients T. B. Drüeke Necker Hospital, Paris. PTH has been shown to influence cardiac and vascular function and growth, as shown experimentally in in vitro and in vivo etudies, and alco-in-human subjects with normal renal function. Because of the increased prevalence of hyperparathyroidism in chronic renal failure (CRF), these alterations have long been felt to contribute to the increased prevalence of cardiovascular disease and hypertension seen in this patient population. PTH (and also PTHrP) have been shown to increase acutely the force and frequency of contraction of isolated, beating rat cardiomyocytos. It has been, suggested that increased inotropy produced by PTH and PTHrP is due to effects on coronary flow and heart rate and not to effects on contractile function. However, changes induced by PTH occur in association with an increase of cell calcium and cyclic AMP. In isolated myocardial mitochondria PTH uncoupled oxidative phosphorylation and inhibited myocardial energy production, leading to reduced ATP content and impaired activity of creatine kinase. Like the chronic inhibitory effects of PTH on myocardial contractility, these responses could be reversed by verapamil. In a uremic rat model elevated cytosolic Ca2+ in cardiomyocytes was associated with attenuated IGF-1 stimulated protein synthesis that could be reversed either by parathyroidectomy or felodipine, suggesting yet another mechanism by which elevated intracellular calcium and 2.º hyperparathyroidism might modulate myocardial growth and structure in uremia. The above noted experimental studies suggest that prolonged exposure to PTH is associated with a greater intramyocardiocyte Ca2+ and with adverse effects on myocardial metabolism, structure, and function. An increase of cytoplasmic Ca2+ by excessive PTH levels has also been found in uremic patients in whom elevated platelet Ca2+ was correlated with plasma PTH and which could be corrected by parathyroidectomy of calcitriol treatment. 76 In rats with CRF the PTH/PTHrP receptor is downregulated. This may serve to desensitize tissues to PTH effects and thus minimize increases in cellular calcium, possibly as part of a negative feedback mechanism. In humans with CRF, as in 1.º hyperparathyroidism, the presence of 2.º hyperparathyroidism has been associated with increased myocardial calcium content and impaired ventricular systolic and diastolic function. Moreover, both 1.º and 2.º hyperparathyroidism are associated with left ventricular hypertrophy (LVH). There are theoretically several mechanisms by which parathyroid excess could favor LVH and cardiac dysfunction. They include direct trophic effects on cardiomyocytes and interstitial fibroblasts and indirect effects such as a blood pressure increase via hypercalcemia, hyperphosphatemia and anemia, as well as pathologic large and small vessels changes secondary to disturbances of lipid and carbohydrate metabolism and to soft-tissue calcifications associated with chronic PTH excess However, parathyroidectomy is not consistently associated with improvement in left ventricular hypertrophy and function, suggesting either PTH-induced changes became irreversible in the case of long-standing, severe hyperparathyroidism, for example by the induction of interstitial fibrosis, or that other factors contributing to myocardial dysfunction were more important than parathyroid overfunction. In conclusion, the hyperparathyroid stale of chronic renal failure contributes to the cardiovascular pathology seen clinically in uremic patients and also to the excess mortality from cardiovascular causes found in this patient group. REVIEW ARTICLE Rostand SG, Drüeke TB: Parathyroid hormone, vitamin D, and cardiovascular disease in chronic renal failure. Kidney Int 56: 383-392, 1999. "
    "pdfFichero" => "P7-E170-S140-A1913.pdf"
    "tienePdf" => true
  ]
  "idiomaDefecto" => "en"
  "url" => "/02116995/00000020000000S1/v0_201502091333/X0211699500025419/v0_201502091333/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "35407"
    "tipo" => "SECCION"
    "es" => array:2 [
      "titulo" => "Suplementos"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "es"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/02116995/00000020000000S1/v0_201502091333/X0211699500025419/v0_201502091333/en/P7-E170-S140-A1913.pdf?idApp=UINPBA000064&text.app=https://revistanefrologia.com/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699500025419?idApp=UINPBA000064"
]
Información del artículo
ISSN: 02116995
Idioma original: Inglés
Datos actualizados diariamente
año/Mes Html Pdf Total
2024 Noviembre 9 20 29
2024 Octubre 34 48 82
2024 Septiembre 27 27 54
2024 Agosto 46 47 93
2024 Julio 43 43 86
2024 Junio 40 28 68
2024 Mayo 58 35 93
2024 Abril 39 27 66
2024 Marzo 42 19 61
2024 Febrero 40 37 77
2024 Enero 23 20 43
2023 Diciembre 21 29 50
2023 Noviembre 29 27 56
2023 Octubre 30 27 57
2023 Septiembre 26 23 49
2023 Agosto 41 28 69
2023 Julio 34 49 83
2023 Junio 73 19 92
2023 Mayo 42 29 71
2023 Abril 46 16 62
2023 Marzo 49 17 66
2023 Febrero 38 18 56
2023 Enero 56 19 75
2022 Diciembre 37 27 64
2022 Noviembre 29 29 58
2022 Octubre 30 26 56
2022 Septiembre 27 25 52
2022 Agosto 28 35 63
2022 Julio 28 35 63
2022 Junio 20 31 51
2022 Mayo 19 24 43
2022 Abril 33 35 68
2022 Marzo 27 42 69
2022 Febrero 28 32 60
2022 Enero 24 23 47
2021 Diciembre 19 31 50
2021 Noviembre 25 26 51
2021 Octubre 35 43 78
2021 Septiembre 12 27 39
2021 Agosto 25 20 45
2021 Julio 18 22 40
2021 Junio 14 13 27
2021 Mayo 27 16 43
2021 Abril 33 46 79
2021 Marzo 30 8 38
2021 Febrero 21 15 36
2021 Enero 8 9 17
2020 Diciembre 16 9 25
2020 Noviembre 8 4 12
2020 Octubre 12 7 19
2020 Septiembre 10 1 11
2020 Agosto 24 8 32
2020 Julio 16 5 21
2020 Junio 13 12 25
2020 Mayo 14 12 26
2020 Abril 35 12 47
2020 Marzo 10 11 21
2020 Febrero 26 16 42
2020 Enero 30 15 45
2019 Diciembre 9 13 22
2019 Noviembre 10 9 19
2019 Octubre 6 6 12
2019 Septiembre 6 10 16
2019 Agosto 4 15 19
2019 Julio 15 11 26
2019 Junio 8 3 11
2019 Mayo 7 6 13
2019 Abril 31 23 54
2019 Marzo 14 10 24
2019 Febrero 5 9 14
2019 Enero 14 6 20
2018 Diciembre 20 15 35
2018 Noviembre 17 6 23
2018 Octubre 11 6 17
2018 Septiembre 19 4 23
2018 Agosto 16 7 23
2018 Julio 13 6 19
2018 Junio 11 6 17
2018 Mayo 14 8 22
2018 Abril 9 3 12
2018 Marzo 13 5 18
2018 Febrero 11 6 17
2018 Enero 7 3 10
2017 Diciembre 8 4 12
2017 Noviembre 9 5 14
2017 Octubre 10 1 11
2017 Septiembre 5 6 11
2017 Agosto 17 6 23
2017 Julio 7 5 12
2017 Junio 17 5 22
2017 Mayo 4 1 5
2017 Abril 4 1 5
2017 Marzo 6 1 7
2017 Febrero 1 0 1
2017 Enero 2 2 4
2016 Diciembre 5 2 7
2016 Noviembre 13 3 16
2016 Octubre 31 3 34
2016 Septiembre 27 1 28
2016 Agosto 48 5 53
2016 Julio 70 0 70
2016 Junio 60 0 60
2016 Mayo 59 0 59
2016 Abril 5 0 5
2016 Marzo 13 0 13
2016 Febrero 26 0 26
2016 Enero 33 0 33
2015 Diciembre 47 0 47
2015 Noviembre 32 0 32
2015 Octubre 26 0 26
2015 Septiembre 38 0 38
2015 Agosto 24 0 24
2015 Julio 18 0 18
2015 Junio 10 0 10
2015 Mayo 13 0 13
Mostrar todo

Siga este enlace para acceder al texto completo del artículo

Idiomas
Nefrología
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?